Literature DB >> 23043761

Orphan receptor TR3 is essential for the maintenance of stem-like properties in gastric cancer cells.

Yan-yan Zhan1, Jian-ping He, Hang-zi Chen, Wei-jia Wang, Jian-chun Cai.   

Abstract

The orphan receptor TR3 is an important regulator of cell proliferation and apoptosis. However, whether TR3 is involved in regulating the stem-like properties of cancer cells remains unknown. The present study shows that TR3 expression is increased in gastric tumorsphere cells and is positively correlated with cancer stem cell (CSC) characteristics. Knocking down TR3 leads to the suppression of its stem-like properties in both gastric cancer cells and tumorsphere cells. This process involves the decreased expression of the stemness-related genes Oct-4 and Nanog and the invasion-related gene MMP-9. We further identify Nanog as a new target for the transcription factor TR3. Together, these data demonstrate for the first time that TR3 is essential for the maintenance of stem-like properties in human gastric cancer cells and implicate TR3 as a new therapeutic target for gastric cancer.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043761     DOI: 10.1016/j.canlet.2012.09.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.

Authors:  Ning Li; Wenying Deng; Jie Ma; Bing Wei; Kang Guo; Wei Shen; Yanping Zhang; Suxia Luo
Journal:  Med Oncol       Date:  2014-12-10       Impact factor: 3.064

2.  Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma.

Authors:  Alexandra Lacey; Erik Hedrick; Yating Cheng; Kumaravel Mohankumar; Melanie Warren; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2018-09-06       Impact factor: 6.261

3.  The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.

Authors:  Erik Hedrick; Syng-Ook Lee; Stephen Safe
Journal:  Mol Carcinog       Date:  2017-05-09       Impact factor: 4.784

4.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

Review 5.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

6.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

Review 7.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02

Review 8.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

Review 9.  Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment.

Authors:  Kang Li; Zeng Dan; Yu-Qiang Nie
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

10.  NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth.

Authors:  Keshav Karki; Kumaravel Mohankumar; Abigail Schoeller; Gregory Martin; Rupesh Shrestha; Stephen Safe
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.